SI1742957T1 - Postopek za pripravo telitromicina - Google Patents
Postopek za pripravo telitromicinaInfo
- Publication number
- SI1742957T1 SI1742957T1 SI200530112T SI200530112T SI1742957T1 SI 1742957 T1 SI1742957 T1 SI 1742957T1 SI 200530112 T SI200530112 T SI 200530112T SI 200530112 T SI200530112 T SI 200530112T SI 1742957 T1 SI1742957 T1 SI 1742957T1
- Authority
- SI
- Slovenia
- Prior art keywords
- formula
- xiia
- benzoyl
- preparation
- deoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN491MU2004 | 2004-04-28 | ||
EP05775551A EP1742957B1 (en) | 2004-04-28 | 2005-04-25 | Process for the preparation of telithromycin |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1742957T1 true SI1742957T1 (sl) | 2008-04-30 |
Family
ID=35159987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200530112T SI1742957T1 (sl) | 2004-04-28 | 2005-04-25 | Postopek za pripravo telitromicina |
Country Status (10)
Country | Link |
---|---|
US (1) | US20070260066A1 (sl) |
EP (1) | EP1742957B1 (sl) |
AT (1) | ATE373009T1 (sl) |
AU (1) | AU2005238313A1 (sl) |
CA (1) | CA2559281A1 (sl) |
DE (1) | DE602005002475T2 (sl) |
ES (1) | ES2294733T3 (sl) |
PL (1) | PL1742957T3 (sl) |
SI (1) | SI1742957T1 (sl) |
WO (1) | WO2005105821A2 (sl) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2664331B1 (en) | 2003-03-10 | 2015-09-16 | Merck Sharp & Dohme Corp. | Novel Antibacterial Agents |
WO2007039914A2 (en) * | 2005-10-06 | 2007-04-12 | Alembic Limited | Novel polymorphs of telithromycin |
WO2007049296A2 (en) * | 2005-10-28 | 2007-05-03 | Alembic Limited | Amorphous form of telithromycin |
US20070167382A1 (en) * | 2005-11-15 | 2007-07-19 | Nina Finkelstein | Crystalline and amorphous forms of telithromycin |
WO2007069264A2 (en) * | 2005-12-15 | 2007-06-21 | Alembic Limited | Reference standards for determining the purity of telithromycin and processes therefor |
GB0600238D0 (en) | 2006-01-06 | 2006-02-15 | Sandoz Ag | Organic compounds |
WO2008007388A1 (en) * | 2006-07-12 | 2008-01-17 | Alembic Limited | Novel process for the preparation of telithromycin |
WO2008023383A1 (en) * | 2006-08-25 | 2008-02-28 | Alembic Limited | Novel process for the preparation of telithromycin |
ES2306590B1 (es) * | 2006-12-15 | 2009-08-07 | Ercros Industrial,S .A. | Formas cristalinas i y ii de telitromicina. |
ES2310121B1 (es) * | 2007-04-19 | 2009-09-11 | Ercros Industrial, S.A. | Nuevo proceso de sintesis de telitromicina. |
WO2009053259A1 (en) * | 2007-10-25 | 2009-04-30 | Sandoz Ag | Process for the production of telithromycin |
AU2008316830B2 (en) | 2007-10-25 | 2016-03-17 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
CN107854477A (zh) | 2008-10-24 | 2018-03-30 | 森普拉制药公司 | 使用含三唑的大环内酯治疗抗性疾病的方法 |
US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
JP5914335B2 (ja) | 2009-09-10 | 2016-05-11 | センプラ ファーマシューティカルズ,インコーポレイテッド | マラリア、結核、及びmac病の治療方法 |
BR112012023950A2 (pt) | 2010-03-22 | 2016-07-05 | Cempra Pharmaceuticals Inc | formas cristalinas de um macrolídeo, e usos dos mesmos |
CN105198944B (zh) | 2010-05-20 | 2018-06-01 | 森普拉制药公司 | 制备大环内酯和酮内酯及其中间体的方法 |
KR20180110181A (ko) | 2010-09-10 | 2018-10-08 | 셈프라 파마슈티컬스, 인크. | 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드 |
NZ700182A (en) | 2012-03-27 | 2017-02-24 | Cempra Pharmaceuticals Inc | Parenteral formulations for administering macrolide antibiotics |
RU2015138796A (ru) | 2013-03-14 | 2017-04-19 | Семпра Фармасьютикалс, Инк. | Способы и составы для лечения респираторных заболеваний |
KR20160020403A (ko) | 2013-03-15 | 2016-02-23 | 셈프라 파마슈티컬스, 인크. | 매크로라이드 항세균제들을 제조하기 위한 수렴 프로세스들 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL99995A (en) * | 1990-11-21 | 1997-11-20 | Roussel Uclaf | Erythromycin derivatives, their preparation and pharmaceutical compositions containing them |
FR2719587B1 (fr) * | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
FR2732684B1 (fr) * | 1995-04-06 | 1997-04-30 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
-
2005
- 2005-04-25 SI SI200530112T patent/SI1742957T1/sl unknown
- 2005-04-25 ES ES05775551T patent/ES2294733T3/es active Active
- 2005-04-25 CA CA002559281A patent/CA2559281A1/en not_active Abandoned
- 2005-04-25 AU AU2005238313A patent/AU2005238313A1/en not_active Abandoned
- 2005-04-25 PL PL05775551T patent/PL1742957T3/pl unknown
- 2005-04-25 DE DE602005002475T patent/DE602005002475T2/de not_active Expired - Fee Related
- 2005-04-25 AT AT05775551T patent/ATE373009T1/de not_active IP Right Cessation
- 2005-04-25 US US10/591,889 patent/US20070260066A1/en not_active Abandoned
- 2005-04-25 WO PCT/IN2005/000125 patent/WO2005105821A2/en active IP Right Grant
- 2005-04-25 EP EP05775551A patent/EP1742957B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
DE602005002475T2 (de) | 2008-05-29 |
WO2005105821A3 (en) | 2006-04-27 |
ATE373009T1 (de) | 2007-09-15 |
PL1742957T3 (pl) | 2008-05-30 |
CA2559281A1 (en) | 2005-11-10 |
US20070260066A1 (en) | 2007-11-08 |
EP1742957A2 (en) | 2007-01-17 |
DE602005002475D1 (de) | 2007-10-25 |
EP1742957B1 (en) | 2007-09-12 |
ES2294733T3 (es) | 2008-04-01 |
WO2005105821A2 (en) | 2005-11-10 |
AU2005238313A1 (en) | 2005-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1742957T3 (pl) | Sposób otrzymywania telitromycyny | |
MY142768A (en) | Gfat inhibitors | |
NO20082338L (no) | Pyrimidinderivater for behandling av avvikende cellevekst | |
MX2010006179A (es) | Formas solidas de acido 3-(6-(1-(2,2-difluorobenzo[d] [1,3]dioxol-5-il)ciclopropancarboxamido)-3-metilpiridin-2-il)benz oico. | |
NZ601786A (en) | Novel compounds and compositions and methods of use | |
NO20064077L (no) | Kemokinreseptorantagonister | |
WO2005082892A3 (en) | Triazole compounds as antibacterial agents and pharmaceutical compositions containing them | |
UA85698C2 (ru) | Хинолиновые промежуточные соединения для синтеза ингибиторов рецепторной тирозинкиназы и способ их получения | |
HK1099688A1 (en) | 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives having cb1- antagonistic activity | |
GEP20115171B (en) | Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor | |
NO20070089L (no) | DPP-IV inhibitorer | |
WO2007084914A3 (en) | Phenoxy-substituted pyrimidines as adenosine receptor antagonists | |
MY148636A (en) | Benzimidazole derivatives | |
TW200512206A (en) | 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amion]-propionic acid ethylester-methanesulfonate and its use as a medicament | |
TW200612949A (en) | Pyrimidine derivatives for the treatment of abnormal cell growth | |
WO2004050637A3 (en) | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors | |
MXPA06013164A (es) | Derivados de pirimidina para el tratamiento de crecimiento de celulas anormal. | |
PT2049480E (pt) | Derivados de 2-arilindole como inibidores da mpges-i | |
MY186650A (en) | Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives | |
ATE374190T1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
MX2009006636A (es) | Nuevos intermediarios y procesos utiles en la rpeparacion de {2-[1-(3,5-bis-trifluorometil-bencil)-5-piridin-4-il-1h-[1,2,3]tr iazol-4-il]-piridin-3-il}-(2-clorofenil)-metanona. | |
DE602005019316D1 (en) | Aromatische etherderivate als thrombin-hemmer | |
MXPA05013751A (es) | Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales. | |
TNSN07006A1 (en) | Novel heterocyclic compounds | |
WO2008087654A3 (en) | PIPERIDINES AS INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 |